Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis.
about
Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.The endocannabinoid system as an emerging target of pharmacotherapyMarijuana and cannabinoid regulation of brain reward circuitsOpioid receptor heteromers in analgesiaΔ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in miceAdenosine-cannabinoid receptor interactions. Implications for striatal functionA neurobiological basis for substance abuse comorbidity in schizophreniaThe Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisNeurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineThe effects of cannabis use on salience attribution: a systematic review.Mice expressing a "hyper-sensitive" form of the CB1 cannabinoid receptor (CB1) show modestly enhanced alcohol preference and consumption.Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.Dopamine challenge reveals neuroadaptive changes in marijuana abusers.Animal models of cannabinoid reward.Cannabinoid receptor localization in brain: relationship to motor and reward systems.Interactions between dopamine transporter and cannabinoid receptor ligands in rhesus monkeysThe decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ anA role for phasic dopamine release within the nucleus accumbens in encoding aversion: a review of the neurochemical literature.Drug addiction.The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia.Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats.The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist.Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.Pharmacological treatment of cannabis dependence.Common intracellular actions of chronic morphine and cocaine in dopaminergic brain reward regions.Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawalDopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study.Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways.Prefrontal dopamine regulates fear reinstatement through the downregulation of extinction circuitsAddiction and brain reward and antireward pathways.Self-administration of cannabinoids by experimental animals and human marijuana smokers.Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems.Modulation of the endocannabinoid system: therapeutic potential against cocaine dependenceEndocannabinoid system involvement in brain reward processes related to drug abuseStriatal D(2)/D(3) receptor availability is inversely correlated with cannabis consumption in chronic marijuana users.Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO.Acute effects of THC on time perception in frequent and infrequent cannabis usersFurther human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum.Cannabis cue-elicited craving and the reward neurocircuitry.
P2860
Q22251269-6E17C317-B673-4C98-9969-418CA6EB21E7Q24648473-3C59B6D0-EAA6-4029-9DE4-BD2516EF3DF5Q24671514-8CDC1F2C-1448-4674-BC7C-D57BFCA0768CQ27004306-290527FE-A446-489F-AA6A-8AE8A6A1EA78Q27345385-056204A5-1185-4023-9DAB-642059DB8F74Q28286488-1B32C2E4-84CA-40EA-9E96-341E2E787BAFQ28347063-014A43A2-2641-4112-A2A0-1F53E6A5F25DQ30047193-ABAB80CE-806A-4EFF-B957-DDECE551628FQ30417935-332EDF39-9C78-4DD4-9F18-602359799AF1Q31143453-40D2C7CC-F05E-4B33-9204-0A7F5B5CC845Q33585822-4079D066-EABE-4CA8-8343-08EB79F5388EQ33886277-AFDA873F-ECDC-43E8-A9EC-7B6B202A28EEQ34082931-F17488F0-E725-4FA6-ADCE-B7F85C0C09A9Q34098204-936F6D3C-3EFE-4D7C-80C8-DF3BC7A03708Q34251331-E7AB1632-5C85-4BD2-8EB8-7E52C39951B6Q34257459-07060805-1C87-4123-A71B-1A98B04D247AQ34267133-B3646CF4-DE21-44E3-A273-95A3ECC8FF56Q34452899-B7FA149D-3CB3-4EA6-B504-733173CBB4A0Q34575484-F568FDC9-0F57-443C-98FA-2ABE03B51C5FQ34988386-E322E20A-8121-4EAD-A8C6-D7BEA8C9F463Q35041427-845EAEC9-E003-4DE8-AEFD-668E9236197CQ35045001-5F457812-83FE-48FF-9A3E-02AE9867E6AFQ35046370-4C6C6E45-4BF4-4AC7-887A-CD12CC3B6512Q35193322-6AF629D3-26A8-44CA-82CB-68B553937FC4Q35210350-E6F13946-C62E-49EA-A86A-7EFE100B4F19Q35260250-E7869488-B637-41F2-A579-E5D83915375FQ35589974-7C6294B1-B178-451D-920E-CB038265FAA9Q35857033-02A4DA44-B460-4080-9D47-B1076AF531D0Q35982298-D27BAEB0-F2B8-41B9-8C64-6CA47C9DA075Q35989378-1EE936E2-4023-4C8C-9B1C-54A715246ED9Q35995170-6DDA22C0-66A9-44EA-A2E8-EDF90D10929FQ36149174-163ED222-06A1-4F92-BFB9-091F9488C8E7Q36234294-30A44919-43A9-4880-A61A-E42DFF37E0C8Q36259799-14E59E75-3721-4FC6-8011-398F6872CBABQ36357182-3FCE3393-7965-41E1-A831-E020D4CAE067Q36496045-651D026F-EBA0-40DB-BD84-8F19451FC4B0Q36610068-4530A626-A5BB-401F-BB5B-6496DEB957D2Q36636653-2DD7E7EB-274E-4F3F-B330-CB73F25A5EA3Q36751811-1AFC7FFC-74B4-4948-8959-BE7CA178A886Q36757474-CAE1CF88-0DA2-49EB-A001-FD31A049E36B
P2860
Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@ast
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@en
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@nl
type
label
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@ast
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@en
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@nl
prefLabel
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@ast
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@en
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@nl
P2093
P921
P356
P1433
P1476
Delta 9-tetrahydrocannabinol p ...... y intracerebral microdialysis.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF02245916
P577
1990-01-01T00:00:00Z
P6179
1036936657